-
-
FLUOROURACIL (Generic for CARAC)
- QTY 30
- 0.5 %
- Cream (g)
- Near The Woodlands, Texas 77381
FLUOROURACIL (flure oh YOOR a sil) treats rough, scaly spots on the skin caused by sun exposure. It may also be used to treat skin cancer. It works by slowing down the growth of irregular skin cells.
Change Location
Set Price Drop Alert for:
FLUOROURACIL (Generic for CARAC)
- QTY 30
- 0.5 %
- Cream (g)
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
FLUOROURACIL (Generic for CARAC)
- QTY 30
- 0.5 %
- Cream (g)
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
FLUOROURACIL (Generic for CARAC) Lifestyle Interactions
-
Fluorouracil 0.5%, Topical cream
• Interaction: Cannabis• Severity: Major• Notes for Consumers: Discuss cannabis use with your care team. The effects of cannabis may be altered if used with your medication. Call emergency services right away if you experience slow or shallow breathing, shortness of breath, feeling faint, dizziness, confusion, or trouble staying awake.• Notes for Professionals: Advise patients to avoid cannabis use during fluorouracil treatment. Concomitant use may alter the exposure of some cannabinoids and increase the risk for adverse reactions. The cannabinoid delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are CYP2C9 substrates and fluorouracil is a moderate CYP2C9 inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
